ArticleArthritis & rheumatology (Hoboken, N.J.)2026

Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus.

Takehiro Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.